Alliancebernstein L.P. Rhythm Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 59,570 shares of RYTM stock, worth $3.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,570

Previous 61,070 2.46%

Holding current value

$3.69 Million

Previous $2.51 Million 24.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$40.81 - $55.0 $61,215 - $82,500	-1,500 Reduced 2.46%	59,570 $3.12 Million
Q2 2024 Aug 14, 2024	BUY	$35.41 - $44.37 $270,532 - $338,986	7,640 Added 14.3%	61,070 $2.51 Million
Q1 2024 May 14, 2024	SELL	$39.12 - $52.44 $37,555 - $50,342	-960 Reduced 1.77%	53,430 $2.32 Million
Q2 2023 Aug 15, 2023	BUY	$16.32 - $21.15 $887,644 - $1.15 Million	54,390 New	54,390 $896,000
Q2 2022 Aug 15, 2022	SELL	$3.12 - $12.25 $140,088 - $550,025	-44,900 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$6.13 - $12.24 $613 - $1,224	100 Added 0.22%	44,900 $517,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $27,583 - $44,480	3,200 Added 7.69%	44,800 $447,000
Q1 2021 May 06, 2021	BUY	$20.25 - $39.49 $30,375 - $59,235	1,500 Added 3.74%	41,600 $885,000
Q3 2020 Nov 12, 2020	SELL	$18.13 - $30.61 $21,756 - $36,732	-1,200 Reduced 2.91%	40,100 $869,000
Q2 2020 Aug 13, 2020	BUY	$14.41 - $25.35 $243,529 - $428,415	16,900 Added 69.26%	41,300 $921,000
Q4 2019 Feb 18, 2020	BUY	$19.53 - $25.5 $23,436 - $30,600	1,200 Added 5.17%	24,400 $560,000
Q3 2019 Nov 14, 2019	BUY	$18.62 - $24.51 $83,790 - $110,295	4,500 Added 24.06%	23,200 $501,000
Q2 2019 Aug 14, 2019	BUY	$21.11 - $28.48 $63,330 - $85,440	3,000 Added 19.11%	18,700 $411,000
Q1 2019 May 14, 2019	SELL	$24.76 - $31.66 $22,284 - $28,494	-900 Reduced 5.42%	15,700 $430,000
Q4 2018 Feb 13, 2019	BUY	$24.11 - $31.34 $94,029 - $122,226	3,900 Added 30.71%	16,600 $446,000
Q3 2018 Nov 08, 2018	BUY	$26.99 - $35.85 $145,746 - $193,590	5,400 Added 73.97%	12,700 $370,000
Q2 2018 Aug 13, 2018	BUY	$17.02 - $35.2 $124,246 - $256,960	7,300 New	7,300 $228,000

Others Institutions Holding RYTM

# of Institutions

192

Shares Held

67.3M

Call Options Held

834K

Put Options Held

78.6K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.46B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Rhythm Pharmaceuticals, Inc. Transaction History